Anti-fibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders (Protocol)
<p>This is the protocol for a review and there is no abstract. The objectives are as follows:</p><p>To determine the efficacy and safety of anti-fibrinolytics (lysine analogues) in preventing bleeding in patients with haematological disorders.</p>
| Glavni autori: | , , , , , , |
|---|---|
| Format: | Journal article |
| Izdano: |
Cochrane Collaboration
2016
|
| _version_ | 1826266084677779456 |
|---|---|
| author | Wardrop, D Estcourt, L Doree, C Hopewell, S Brunskill, S Stanworth, S Murphy, M |
| author_facet | Wardrop, D Estcourt, L Doree, C Hopewell, S Brunskill, S Stanworth, S Murphy, M |
| author_sort | Wardrop, D |
| collection | OXFORD |
| description | <p>This is the protocol for a review and there is no abstract. The objectives are as follows:</p><p>To determine the efficacy and safety of anti-fibrinolytics (lysine analogues) in preventing bleeding in patients with haematological disorders.</p> |
| first_indexed | 2024-03-06T20:33:35Z |
| format | Journal article |
| id | oxford-uuid:31dc9dde-51a2-4e2b-85a3-b51b194b95d0 |
| institution | University of Oxford |
| last_indexed | 2024-03-06T20:33:35Z |
| publishDate | 2016 |
| publisher | Cochrane Collaboration |
| record_format | dspace |
| spelling | oxford-uuid:31dc9dde-51a2-4e2b-85a3-b51b194b95d02022-03-26T13:10:38ZAnti-fibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders (Protocol)Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:31dc9dde-51a2-4e2b-85a3-b51b194b95d0Symplectic Elements at OxfordCochrane Collaboration2016Wardrop, DEstcourt, LDoree, CHopewell, SBrunskill, SStanworth, SMurphy, M<p>This is the protocol for a review and there is no abstract. The objectives are as follows:</p><p>To determine the efficacy and safety of anti-fibrinolytics (lysine analogues) in preventing bleeding in patients with haematological disorders.</p> |
| spellingShingle | Wardrop, D Estcourt, L Doree, C Hopewell, S Brunskill, S Stanworth, S Murphy, M Anti-fibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders (Protocol) |
| title | Anti-fibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders (Protocol) |
| title_full | Anti-fibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders (Protocol) |
| title_fullStr | Anti-fibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders (Protocol) |
| title_full_unstemmed | Anti-fibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders (Protocol) |
| title_short | Anti-fibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders (Protocol) |
| title_sort | anti fibrinolytics lysine analogues for the prevention of bleeding in patients with haematological disorders protocol |
| work_keys_str_mv | AT wardropd antifibrinolyticslysineanaloguesforthepreventionofbleedinginpatientswithhaematologicaldisordersprotocol AT estcourtl antifibrinolyticslysineanaloguesforthepreventionofbleedinginpatientswithhaematologicaldisordersprotocol AT doreec antifibrinolyticslysineanaloguesforthepreventionofbleedinginpatientswithhaematologicaldisordersprotocol AT hopewells antifibrinolyticslysineanaloguesforthepreventionofbleedinginpatientswithhaematologicaldisordersprotocol AT brunskills antifibrinolyticslysineanaloguesforthepreventionofbleedinginpatientswithhaematologicaldisordersprotocol AT stanworths antifibrinolyticslysineanaloguesforthepreventionofbleedinginpatientswithhaematologicaldisordersprotocol AT murphym antifibrinolyticslysineanaloguesforthepreventionofbleedinginpatientswithhaematologicaldisordersprotocol |